<DOC>
	<DOC>NCT00574886</DOC>
	<brief_summary>This trial was made available as a compassionate use protocol for patients who failed induction chemotherapy + Vaccine on trials 197-99 and 196-99. These follicular NHL patients then went on to high dose BEAM chemotherapy and transplant. Patients received idiotype vaccine therapy at 3 months post transplant. Vaccine was given monthly x 4 series, with a fifth series given 12 weeks after the fourth. Patients are then followed annually until progression or death with standard staging. Immune response testing continues annually on patients who continue to have a response post transplant.</brief_summary>
	<brief_title>Idiotype Vaccine Following High-Dose Chemotherapy and Hematopoietic Stem Cell Transplantation for Patients With Lymphoma Who Had Failed Induction Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Immunoglobulin Idiotypes</mesh_term>
	<criteria>histologically confirmed aggressive or indolent, Bcell nonhodgkins lymphoma original enrollment in vaccine protocol for newly diagnosed lymphoma and had successful production of idiotype vaccine failed to achieve PR or CR with initial induction chemotherapy, received salvage chemotherapy and then stem cell transplant and achieved a CR or good PR following transplantation &gt;/= 19 years signed informed consent nonpregnant, nonlactating serious disease or condition that, in the opinion of the investigator, would compromise the subject's ability to participate in the study.</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>